Sabra Health Care REIT, Inc. (SBRA) SEC Filings & Earnings Calls
EquiReason read 12 Sabra Health Care REIT, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-03 — Net (loss) income attributable to Sabra Health Care REIT, Inc. $-25M; FFO attributable to Sabra Health Care REIT, Inc. $-5M; Normalized FFO attributable to Sabra Health Care REIT, .
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 5.0B
- P/E TTM
- 75.2
- Dividend yield
- 6.1%
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
3 Aug 20268-K · 2.02, 7.01Net (loss) income attributable to Sabra Health Care REIT, Inc. $-25M; FFO attributable to Sabra Health Care REIT, Inc. $-5M; Normalized FFO attributable to Sabra Health Care REIT, Inc. $98M (+10% y/y); Guidance: Normalized FFO per share guiearningsopen
Figures in the filing · each found in the filing text
| Net (loss) income attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026 | $-25M | |
| FFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026 | $-5M | |
| Normalized FFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026 | $98M | +10% y/y |
| AFFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026 | $100M | +12% y/y |
| Normalized AFFO attributable to Sabra Health Care REIT, Inc. · Consolidated · Q2-2026 | $103M | +13% y/y |
| Normalized FFO per diluted common share · Consolidated · Q2-2026 | $0.38 | +3% y/y |
| Normalized AFFO per diluted common share · Consolidated · Q2-2026 | $0.40 | +5% y/y |
| Provision for loan losses and other reserves · Consolidated · Q2-2026 | $102M |
Guidance
Normalized FFO per share guidance $1.53-$1.55; Normalized AFFO per share $1.59-$1.61.
Maintained FY2026 guidance; expects low-single-digit Cash NOI growth for triple-net and low-to-mid-teens for Senior Housing - Managed.
Risks flagged
Large provision for loan losses indicates credit quality deterioration in portfolio.
“Provision for (recovery of) loan losses and other reserves $102,445 vs ($227) prior year.” · word for word
Net loss driven by non-cash charges; core FFO growth positive.
“Net loss of $25.2M but Normalized FFO increased to $98.2M.”
3 Aug 202610-QSabra reported a net loss of $25.2 million in Q2 2026 vs. net income of $65.5 million in Q2 2025, driven by a $100 million write-off on a mortgage loan and a $102.4 million provision for loan losses.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q2-2026 | $236M | +25% y/y |
| Net (loss) income attributable to Sabra Health Care REIT, Inc. · Q2-2026 | $-25M | -138% y/y |
| Net cash provided by operating activities · H1-2026 | $184M | +14% y/y |
| Dividend per share · Q2-2026 | $0.30 | 0% y/y |
| Number of properties · 2026-06-30 | 364 |
Risks flagged
Large credit loss on mortgage loan
“On June 30, 2026, the Company received a reduced cash payment of $200.0 million in full satisfaction of the $300.0 million Recovery Centers of America mortgage loan, resulting in a write-off of $100.0 million.” · word for word
Elevated provision for loan losses
“Provision for (recovery of) loan losses and other reserves $ 102,445 $ (227)”
Net loss in Q2 2026
“Net (loss) income attributable to Sabra Health Care REIT, Inc. $ (25,202) $ 65,542” · word for word
21 Jul 20268-K · 7.01G&A expenses $61M; Cash interest expense $104M; Weighted average share count (Normalized FFO) 258,000,000; Guidance: Normalized FFO per share midpoint $1.54, up 7% YoY; Normalized AFFO per share midpoint $1.60, up 8% YoY.open
Figures in the filing · each found in the filing text
| G&A expenses · FY2026 | $61M | |
| Cash interest expense · FY2026 | $104M | |
| Weighted average share count (Normalized FFO) · FY2026 | 258,000,000 | |
| Weighted average share count (Normalized AFFO) · FY2026 | 259,000,000 | |
| Annualized cash rent (Avamere portfolio) · Avamere Portfolio | $53M | +29% y/y |
Guidance
Normalized FFO per share midpoint $1.54, up 7% YoY; Normalized AFFO per share midpoint $1.60, up 8% YoY.
Raised full-year 2026 guidance driven by portfolio re-tenanting, rent increases, and debt reduction.
Risks flagged
Avamere transition execution risk; tenant transitions may face delays or operational issues.
“Transition is expected to be completed during the second half of 2026.” · word for word
29 Apr 202610-QRevenue $222M (+21% y/y); Net income $41M (+1% y/y); Operating cash flow $98M (+23% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $222M | +21% y/y |
| Net income · Q1-2026 | $41M | +1% y/y |
| Operating cash flow · Q1-2026 | $98M | +23% y/y |
| Dividend per share · Q1-2026 | $0.30 | 0% y/y |
| Total debt · 2026-03-31 | $2.69B | |
| Number of properties · 2026-03-31 | 361 | |
| Acquisitions · Q1-2026 | $96M |
Risks flagged
Interest rate exposure
“Interest expense increased to $28.4M from $27.1M YoY; significant variable-rate debt on revolving credit facility.”
Operating cost inflation in managed portfolio
“Senior housing - managed portfolio operating expenses increased to $81.9M from $56.5M YoY, outpacing revenue growth.”
29 Apr 20268-K · 2.02, 7.01Sabra Health Care REIT reported Q1 2026 results: Normalized FFO per share $0.38 vs $0.35 YoY, AFFO per share $0.39 vs $0.37 YoY. Net income $40.9M vs $40.3M. Net Debt to Adjusted EBITDA 5.04x. No guidance provided.earningsopen
Figures in the filing · each found in the filing text
| Net income · Q1-2026 | $41M | +1% y/y |
Risks flagged
No material risk signals identified in this earnings release.
24 Apr 2026DEF 14AProxy statement for 2026 Annual Meeting of Stockholders, disclosing executive compensation, governance practices, and financial highlights.open
Figures in the filing · each found in the filing text
| Adjusted Normalized FFO Per Share · FY2025 | $1.53 | +4% y/y |
| Net Debt to Adjusted EBITDA · FY2025 | $5.00 | -5% y/y |
| Total Shareholder Return · FY2025 | 17.0% | |
| New Investments · FY2025 | $450M | |
| Liquidity · 2025-12-31 | $1.20B | |
| Net Income · FY2025 | $156M | +23% y/y |
| Total Debt · 2025-12-31 | $2.55B | +5% y/y |
| Acquisitions · FY2025 | $450M |
Risks flagged
Key person succession risk mitigated
“Ms. Nevo-Hacohen retired effective December 31, 2025, and currently serves in a consulting role for Sabra to ensure her many years of expertise provide ongoing continuity for the investment function.” · word for word
12 Feb 202610-KNumber of Properties 360; Total Debt $2.60B; Revolving Credit Facility Availability $782Mopen
Figures in the filing · each found in the filing text
| Number of Properties · FY2025 | 360 | |
| Total Debt · FY2025 | $2.60B | |
| Revolving Credit Facility Availability · FY2025 | $782M |
Risks flagged
Interest Rate Sensitivity
“An increase in market interest rates could increase our interest costs on borrowings on our Revolving Credit Facility and future debt and could adversely affect our stock price.” · word for word
Labor Cost and Shortage
“A shortage of caregivers or other trained personnel, minimum staffing requirements or general inflationary pressures on wages has and may continue to force tenants, borrowers and Senior Housing - Managed communities to enhance pay and benefits packages to compete effectively for skilled personnel” · word for word
Reimbursement Risk
“The reduction in reimbursement rates from third-party payors, including insurance companies and the Medicare and Medicaid programs, or other measures reducing reimbursements for services provided by our tenants and borrowers, may result in a reduction in our tenants’ and borrowers’ revenues and operating margins.” · word for word
12 Feb 20268-K · 2.02, 7.01General and administrative expenses $52M; Cash interest expense $103M; Weighted average share count for Normalized FFO 255,000,000; Guidance: Normalized FFO per share $1.49-$1.53; Normalized AFFO per share $1.55-$1.59earningsopen
Figures in the filing · each found in the filing text
| General and administrative expenses · FY2026 | $52M | |
| Cash interest expense · FY2026 | $103M | |
| Weighted average share count for Normalized FFO · FY2026 | 255,000,000 | |
| Weighted average share count for Normalized AFFO · FY2026 | 256,000,000 |
Guidance
Normalized FFO per share $1.49-$1.53; Normalized AFFO per share $1.55-$1.59
2026 guidance reflects strong same-store growth in senior housing managed portfolio and stable FFO/AFFO metrics.
Risks flagged
Guidance assumes no tenants placed on cash-basis or moved to accrual-basis after Dec 31, 2025
“no tenants are placed on cash-basis or moved to accrual-basis for revenue recognition after December 31, 2025” · word for word
5 Jan 20268-K · 5.02, 7.01Base Salary $470,000.00open
Figures in the filing · each found in the filing text
| Base Salary · FY2026 | $470000.00 |
5 Nov 20258-K · 2.02, 7.01Normalized FFO per share $0.36 (+3% y/y); Normalized AFFO per share $0.38 (+3% y/y); Net income per share $0.09 (-31% y/y); Guidance: Normalized FFO guidance midpoint raised to $1.46 from $1.455earningsopen
Figures in the filing · each found in the filing text
| Normalized FFO per share · Q3-2025 | $0.36 | +3% y/y |
| Normalized AFFO per share · Q3-2025 | $0.38 | +3% y/y |
| Net income per share · Q3-2025 | $0.09 | -31% y/y |
| FFO per share · Q3-2025 | $0.33 | -3% y/y |
| Normalized FFO guidance midpoint · FY2025 | $1.46 | |
| Normalized AFFO guidance midpoint · FY2025 | $1.50 |
Guidance
Normalized FFO guidance midpoint raised to $1.46 from $1.455
2025 Normalized FFO guidance raised slightly, reflecting improved senior housing performance.
Risks flagged
Tenant credit risk from potential cash-basis revenue recognition changes.
“Guidance assumes no tenants are placed on cash-basis or moved to accrual-basis after September 30, 2025.”
5 Nov 202510-QSabra reported Q3 2025 results with revenue growth but net income decline due to higher costs and impairments.earningsopen
Figures in the filing · each found in the filing text
| Total revenues · Q3-2025 | $190M | +7% y/y |
| Net income attributable to Sabra Health Care REIT, Inc. · Q3-2025 | $23M | -24% y/y |
| Cash and cash equivalents · 2025-09-30 | $201M | |
| Number of properties · 2025-09-30 | 363 | |
| Dividend per share · Q3-2025 | $0.30 | 0% y/y |
| Acquisitions (real estate) · 9M-2025 | $283M | +152% y/y |
Risks flagged
Impairment risk from portfolio repositioning
“The Company continues to evaluate additional assets for sale as part of its initiative to recycle capital and further improve its portfolio quality. This could lead to a shorter hold period for such assets and could result in the determination that the full amount of the Company's investment in such assets is not recoverable, resulting in an impairment charg” · word for word
Interest rate exposure
“Unrealized loss on cash flow hedges of $28.9 million for the nine months ended September 30, 2025.”
Sabra Health Care REIT, Inc. — questions
- What did Sabra Health Care REIT, Inc. file recently?
- 12 SEC filings in the last 12 months. Latest: 8-K on 2026-08-03 — Net (loss) income attributable to Sabra Health Care REIT, Inc. $-25M; FFO attributable to Sabra Health Care REIT, Inc. $-5M; Normalized FFO attributable to Sabra Health Care REIT, Inc. $98M (+10% y/y); Guidance: Normalized FFO per share gui
Every figure on this page comes from Sabra Health Care REIT, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.